Inogen (INGN) Revenue (2013 - 2026)
Inogen's (INGN) quarterly Revenue came in at $85.1 million in Q1 2026, up 3.44% year-on-year from $82.3 million in Q1 2025, and up 4.15% on a QoQ basis from $81.7 million in Q4 2025.
Inogen (INGN) Revenue (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Revenue data on file, last reported at $85.1 million in Q1 2026.
- On a quarterly basis, Revenue rose 3.44% year-over-year to $85.1 million in Q1 2026; TTM through Mar 2026 was $351.5 million, a 3.39% increase from a year earlier, with the FY2025 full-year figure at $348.7 million, up 3.86% from the prior year.
- Revenue for Q1 2026 stood at $85.1 million, up from $81.7 million in the prior quarter.
- Over the last five years, Revenue for INGN reached as high as $105.4 million in Q3 2022 and fell as low as $72.2 million in Q1 2023.
- Historically, Revenue has averaged $86.0 million across 5 years, with a median of $84.0 million in 2023.
- Across the five-year window, Revenue soared 30.15% in 2022 and declined 20.33% in 2023, its largest moves.
- Year by year, Revenue stood at $88.1 million in 2022, then retreated by 13.84% to $75.9 million in 2023, then gained by 5.51% to $80.1 million in 2024, then climbed by 2.05% to $81.7 million in 2025, then advanced by 4.15% to $85.1 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $85.1 million in Q1 2026, $81.7 million in Q4 2025, and $92.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.19 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.57 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | 85.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.11 Mn |
| Dec 31, 2025 | 81.72 Mn |
| Sep 30, 2025 | 92.39 Mn |
| Jun 30, 2025 | 92.28 Mn |
| Mar 31, 2025 | 82.28 Mn |
| Dec 31, 2024 | 80.08 Mn |
| Sep 30, 2024 | 88.83 Mn |
| Jun 30, 2024 | 88.77 Mn |
| Mar 31, 2024 | 78.03 Mn |
| Dec 31, 2023 | 75.90 Mn |
| Sep 30, 2023 | 83.97 Mn |
| Jun 30, 2023 | 83.64 Mn |
| Mar 31, 2023 | 72.16 Mn |
| Dec 31, 2022 | 88.09 Mn |
| Sep 30, 2022 | 105.39 Mn |
| Jun 30, 2022 | 103.38 Mn |
| Mar 31, 2022 | 80.39 Mn |
| Dec 31, 2021 | 109.64 Mn |
| Sep 30, 2021 | 80.97 Mn |
| Jun 30, 2021 | 101.56 Mn |